Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:27 pm Sale | 2023-12-31 | 13G | Whole Earth Brands, Inc. FREE | Armistice Capital, LLC | 2,150,000 5.020% | -325,802 (-13.16%) | Filing History |
| 2024-02-14 2:26 pm Sale | 2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Armistice Capital, LLC | 2,064,000 9.800% | -14,000 (-0.67%) | Filing History |
| 2024-02-14 2:26 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Armistice Capital, LLC | 5,200,000 6.490% | 28,000 (+0.54%) | Filing History |
| 2024-02-14 2:25 pm Purchase | 2023-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | Armistice Capital, LLC | 23 9.990% | 17 (+308.69%) | Filing History |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | Armistice Capital, LLC | 2,715,635 9.990% | 1,728,424 (+175.08%) | Filing History |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | ContraFect Corporation CFRXQ | Armistice Capital, LLC | 1,395,093 9.990% | 1,395,093 (New Position) | Filing History |
| 2024-02-14 2:23 pm Unchanged | 2023-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ | Armistice Capital, LLC | 2,666,666 6.750% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:23 pm Purchase | 2023-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 1,078,459 9.990% | 122,464 (+12.81%) | Filing History |
| 2024-02-14 2:22 pm Purchase | 2023-12-31 | 13G | Assertio Holdings, Inc. ASRT | Armistice Capital, LLC | 386,667 6.130% | 386,667 (New Position) | Filing History |
| 2024-02-14 2:21 pm Purchase | 2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 4,626,190 9.990% | 1,629,079 (+54.35%) | Filing History |
| 2024-02-14 2:21 pm Purchase | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Armistice Capital, LLC | 3,524,000 6.310% | 774,000 (+28.15%) | Filing History |
| 2023-06-27 6:02 pm Sale | 2023-06-26 | 13D | Avalo Therapeutics, Inc. AVTX | Armistice Capital, LLC | 2,597 4.990% | -17,331 (-86.97%) | Filing History |
| 2023-02-16 2:49 pm Sale | 2022-12-31 | 13G | Addex Therapeutics Ltd ADXN | Armistice Capital, LLC | 33,765 4.990% | -168,158 (-83.28%) | Filing History |
| 2023-02-14 1:50 pm Purchase | 2022-12-31 | 13G | Midatech Pharma plc MTP | Armistice Capital, LLC | 96,707 8.930% | 96,707 (New Position) | Filing History |
| 2023-02-14 1:48 pm Purchase | 2022-12-31 | 13G | XORTX Therapeutics Inc. XRTX | Armistice Capital, LLC | 18,550 9.990% | 18,550 (New Position) | Filing History |
| 2023-02-14 1:47 pm Purchase | 2022-12-31 | 13G | Exicure, Inc. XCUR | Armistice Capital, LLC | 52,149 4.990% | 52,149 (New Position) | Filing History |
| 2023-02-14 1:44 pm Purchase | 2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 3,396,000 8.800% | 3,396,000 (New Position) | Filing History |
| 2023-02-14 1:43 pm Purchase | 2022-12-31 | 13G | VivoPower International PLC VVPR | Armistice Capital, LLC | 191,690 7.780% | 191,690 (New Position) | Filing History |
| 2023-02-14 1:41 pm Purchase | 2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 97,600 6.080% | 17,600 (+22.00%) | Filing History |
| 2023-02-14 1:39 pm Purchase | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 6,412,000 9.990% | 2,334,000 (+57.23%) | Filing History |